))
NBT # 25 Sarah Kennedy and Dr. Ed Walker: Ozempic & Natural Alternatives that Work
Manage episode 410685336 series 3566825
Το περιεχόμενο παρέχεται από το Tom Aarts. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Tom Aarts ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
On this latest episode of Nutrition Business Today, host Tom Aarts and his guests pick apart this surge of weight loss supplements, that followed the recent 'Ozempic craze'.
Coming all the way from New Zealand, six-time CEO Sarah Kennedy and scientist lecturer at the University of Aukland, Dr. Ed Walker cut through the noise on natural products in this category and what claims have the science to back them up
Ozempic, just one of the pharmaceutical semaglutide injectables developed for diabetes, has stormed the media with its effectiveness when it comes to weight loss and management. But is there cause for concern? Are some users unable to withstand the side effects, or perhaps they are not comfortable with injections? Regardless, consumers are looking for natural alternatives and Calocurb's patented delivery of the main ingredient, Amerasate, is the only natural GLP-1 agonist on the market. With a $20 million research investment from the NZ government, Calocurb has the science to solidify these claims. Join us as we discuss what it takes from a business and science perspective to enter this volatile category.
Find Calocurb at https://www.calocurb.com/
For interested practitioners, visit https://wholesale.calocurb.com/
27 επεισόδια
Μοίρασέ το
